THE LIBRARY · PEER-REVIEWED STUDIES

The science
of nutrition,
at the source

Studies published on the substances we follow, gathered every day from the European database Europe PMC. Each one keeps its title, authors, journal and a link to the original article, whether or not it favours what we sell.

01Only peer-reviewed journals indexed in PubMed
02Automatic collection, with no selection based on a study’s results
03Always a link to the original article
04The level of evidence shown on every study

The studies

268 study(ies) out of 2421
Clear the search and filters
Level 3 · Human studyObservational study2014

Plasma glutamine concentration after intensive care unit discharge: an observational study

Smedberg M, Grass JN, Pettersson L, Norberg Å, Rooyackers O, Wernerman J · Critical care (London, England)

Introduction : Low plasma glutamine concentration at ICU admission is associated with unfavorable outcomes. The prediction of plasma glutamine concentration after ICU discharge on outcomes has not been characterized. In the recent Scandinavian Glutamine Trial, a survival advantage was seen with glutamine…

Level 2 · Controlled trialRandomised controlled trial2014

Glycemic effects and safety of L-Glutamine supplementation with or without sitagliptin in type 2 diabetes patients-a randomized study

Samocha-Bonet D, Chisholm DJ, Gribble FM, Coster AC, Carpenter KH, Jones GR, Holst JJ, Greenfield JR · PloS one

Background and aims : L-glutamine is an efficacious glucagon-like peptide (GLP)-1 secretagogue in vitro. When administered with a meal, glutamine increases GLP-1 and insulin excursions and reduces postprandial glycaemia in type 2 diabetes patients. The aim of the study was to assess the efficacy and safety of daily…

Level 3 · Human studyClinical trial2014

A tracer bolus method for investigating glutamine kinetics in humans

Mori M, Smedberg M, Klaude M, Tjäder I, Norberg A, Rooyackers O, Wernerman J · PloS one

Glutamine transport between tissues is important for the outcome of critically ill patients. Investigation of glutamine kinetics is, therefore, necessary to understand glutamine metabolism in these patients in order to improve future intervention studies. Endogenous glutamine production can be measured by continuous…

Level 1 · SynthesisSystematic review2014

Parenteral glutamine supplementation in critical illness: a systematic review

Wischmeyer PE, Dhaliwal R, McCall M, Ziegler TR, Heyland DK · Critical care (London, England)

Introduction : The potential benefit of parenteral glutamine (GLN) supplementation has been one of the most commonly studied nutritional interventions in the critical care setting. The aim of this systematic review was to incorporate recent trials of traditional parenteral GLN supplementation in critical illness with…

Level 2 · Controlled trialRandomised controlled trial2014

Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation

Mori M, Rooyackers O, Smedberg M, Tjäder I, Norberg A, Wernerman J · Critical care (London, England)

Introduction : Glutamine rate of appearance (Ra) may be used as an estimate of endogenous glutamine production. Recently a technique employing a bolus injection of isotopically labeled glutamine was introduced, with the potential to allow for multiple assessments of the glutamine Ra over time in critically ill…

Level 1 · SynthesisMeta-analysis2014

The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials

Chen QH, Yang Y, He HL, Xie JF, Cai SX, Liu AR, Wang HL, Qiu HB · Critical care (London, England)

Introduction : Glutamine supplementation is supposed to reduce mortality and nosocomial infections in critically ill patients. However, the recently published reducing deaths due to oxidative stress (REDOX) trials did not provide evidence supporting this. This study investigated the impact of glutamine-supplemented…

Reading a study
in 5 questions

  1. 01Where is it published?In an identifiable peer-reviewed journal (PubMed, DOI).
  2. 02Who was studied?Humans? How many? What age, what state of health?
  3. 03How?Randomised, placebo-controlled, double-blind?
  4. 04What dose?Is it the same dose as in the product you are being sold?
  5. 05Who funded it?Funding and conflicts of interest are declared at the end of the article.

Glossary

Peer review
Before publication, the article is examined by independent researchers from the same field.
Randomised trial
Participants are assigned to the groups at random, so that the groups are comparable.
Double-blind
Neither the participants nor the researchers know who receives what during the study.
Meta-analysis
A statistical analysis that combines the results of several studies on the same question.
Systematic review
A survey of all the studies published on a question, following a method announced in advance.
Observational study
Researchers observe people without assigning them a treatment: it shows a link, not a cause.

Scientific information content; it does not replace the advice of a healthcare professional. The presence of a study in this library does not constitute a claim about our products.

Automatic selection: articles indexed in PubMed whose title names a substance we follow, classified as a meta-analysis, systematic review, trial or observational study. Source of the references: Europe PMC.